When investing in a biotech exchange-traded fund, read the fine print.
The Nasdaq Biotechnology ETF” postfix=””], which attempts to replicate investment results of the Nasdaq Biotechnology Index, shows why. On the fund’s website, the price/earnings ratio of the ETF is listed as 28.29 times. That is pricey, but arguably not unreasonable for a growth sector.
00:02 AT&T Aims for an Empire in Merger Talks With Time Warner5
21:31 Time Warner jumps after hours on report it could sell for $110 per share to AT&T1
23:06 AT&T discussed takeover in meetings with Time Warner: Bloomberg
15:06 How to watch Barcelona vs. Manchester City: Live stream, game time, TV4